Stock listing

Intervacc Ab

Selected listing: IVACC · OMXSTO · SEK · SE

Intervacc Ab (Stockholm:IVACC), Health Technology. Latest release Jul 30, 2026: Intervacc submits Type II variation to EMA seeking 12-month duration…

IVACC:OMXSTOSEKSEUpdated September 26, 2026

Ticker: Stockholm:IVACC
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: Stockholm
Currency: SEK

About Intervacc Ab

The company focuses on developing innovative solutions in the field of veterinary medicine. Intervacc aims to improve animal health and welfare through its research and product offerings.

Latest news from Intervacc Ab

Intervacc submits Type II variation to EMA seeking 12-month duration of immunity for Strangvac

July 30, 2026

Intervacc completes successful evaluation of US strain of strangles pathogen ahead of clinical trials

May 22, 2026

Emil Billbäck appointed new Chair of the Board of Intervacc

May 15, 2026

Intervacc strengthens management team for future growth

May 12, 2026

Intervacc publishes the 2025 Annual Report

April 14, 2026

All Intervacc Ab news →

Research Intervacc Ab

Intervacc Ab company profile

View the public company page for Intervacc Ab on 6ix.

Intervacc Ab news

Read company news and market updates connected to Intervacc Ab.

Intervacc Ab investor events

Find investor webinars, events, and replay context for Intervacc Ab.